Denmark· DK-28104548409
Yellox
A bromfenac product containing bromfenac natrium sesquihydrat, registered in Denmark by PharmaSwiss Ceska republika s.r.. The same ATC class is registered in 15 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Bromfenac is registered in 15 of 19 countries.
Countries holding a registration under ATC S01BC11 (bromfenac), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 9 of them publish a price we can compare per daily dose
Bromfenac · ATC S01BC11
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Bromfenac natrium sesquihydrat
- Manufacturer
- PharmaSwiss Ceska republika s.r.
- Country
- Denmark (DK)
- ATC code
- S01BC11
- ATC class
- Bromfenac
- Defined daily dose
- 66 mcg, AT
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28104548409
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
200 interactions on record for bromfenac.
Graded by severity as the source publishes them — 53 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Bromfenac · interactions on record
200 records
- 53 severe
- 145 moderate
- 2 minor
Most severe, free to view
- WarfarinB01AA03severe
- DalteparinB01AB04severe
- EnoxaparinB01AB05severe
- PrasugrelB01AC22severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under S01BC11
Bromfenac, as other registers publish it.
- CanadaAPO-BROMFENACAPOTEX INC
- PolandBrofestillPharm Supply Sp. z o.o.
- PolandBrofestillPharm Supply Sp. z o.o.
- United StatesbromfenacAlembic Pharmaceuticals Limited
- United StatesbromfenacSun Pharmaceutical Industries, Inc.
- United StatesBromfenacARMAS PHARMACEUTICALS INC.
- United StatesBromfenacAurobindo Pharma Limited
- United StatesBromfenacAmneal Pharmaceuticals NY LLC
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c04468c7-8bf9-4501-ad57-4930706c97b2 GET /v1/drugs/c04468c7-8bf9-4501-ad57-4930706c97b2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "øjendråber, opløsning",
"source": "dkma",
"strength": "0,9 mg/ml",
"auth_role": "RAP",
"dk_drugid": "28104548409",
"substance": "Bromfenac natrium sesquihydrat",
"auth_procedure": "Central",
"in_medicinpriser": false,
"registration_date_serial": "40681"
}See everything about bromfenac.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.